BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29630687)

  • 21. Industry Payments to Physicians for Opioid Products, 2013-2015.
    Hadland SE; Krieger MS; Marshall BDL
    Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas.
    Lee AJ; Bandari J; Macleod LC; Davies BJ; Jacobs BL
    J Gen Intern Med; 2019 Feb; 34(2):187-189. PubMed ID: 30402818
    [No Abstract]   [Full Text] [Related]  

  • 23. Ethical relationships between drug companies and the medical profession.
    Rosner F
    Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765
    [No Abstract]   [Full Text] [Related]  

  • 24. Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted Therapies.
    Hollenbeck BK; Oerline M; Kaufman SR; Caram MEV; Dusetzina SB; Ryan AM; Shahinian VB
    Urology; 2021 Feb; 148():134-140. PubMed ID: 33075381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
    Johar K
    Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
    [No Abstract]   [Full Text] [Related]  

  • 26. The impact of integration on outpatient chemotherapy use and spending in Medicare.
    Jung J; Feldman R; Kalidindi Y
    Health Econ; 2019 Apr; 28(4):517-528. PubMed ID: 30695812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No more free drug samples?
    Chimonas S; Kassirer JP
    PLoS Med; 2009 May; 6(5):e1000074. PubMed ID: 19434227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Industry-Dermatologist Financial Relationship: Insight From the Open Payment Data.
    Feng H; Wu P; Leger M
    JAMA Dermatol; 2016 Dec; 152(12):1307-1313. PubMed ID: 27706478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicare fees and physicians' medicare service volume: beneficiaries treated and services per beneficiary.
    Hadley J; Reschovsky JD
    Int J Health Care Finance Econ; 2006 Jun; 6(2):131-50. PubMed ID: 16783506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?
    Insel TR
    JAMA; 2010 Mar; 303(12):1192-3. PubMed ID: 20332407
    [No Abstract]   [Full Text] [Related]  

  • 31. New Medicare bill targets discrepancies in fees for cancer drugs, outpatient services.
    Twombly R
    J Natl Cancer Inst; 2004 Feb; 96(3):166-8. PubMed ID: 14759976
    [No Abstract]   [Full Text] [Related]  

  • 32. Experts' agency problems: evidence from the prescription drug market in Japan.
    Iizuka T
    Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The geography of Medicare: explaining differences in payment and costs.
    Super N
    NHPF Issue Brief; 2003 Jul; (792):1-19. PubMed ID: 12852426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Value of Considering Cost, and the Cost of Not Considering Value.
    Saltz LB
    J Clin Oncol; 2016 Mar; 34(7):659-60. PubMed ID: 26668345
    [No Abstract]   [Full Text] [Related]  

  • 35. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
    Gostin LO
    JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827
    [No Abstract]   [Full Text] [Related]  

  • 36. Medical commerce, physician entrepreneurialism, and conflicts of interest.
    Rodwin MA
    Camb Q Healthc Ethics; 2007; 16(4):387-97; discussion 439-42. PubMed ID: 18018918
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of Differences in Clinical Activity and Medicare Payments Among Female and Male Radiation Oncologists.
    Valle L; Weng J; Jagsi R; Chu FI; Ahmad S; Steinberg M; Raldow A
    JAMA Netw Open; 2019 Mar; 2(3):e190932. PubMed ID: 30901047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmaceutical industry: friend or foe?
    Niebyl JR
    Am J Obstet Gynecol; 2008 Apr; 198(4):435-9. PubMed ID: 18395035
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of financial relationships on the behaviors of health care professionals: a review of the evidence.
    Robertson C; Rose S; Kesselheim AS
    J Law Med Ethics; 2012; 40(3):452-66. PubMed ID: 23061573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary on "no to greed".
    Hunt DP
    South Med J; 2015 Jan; 108(1):65-6. PubMed ID: 25580762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.